1. 529P Exploratory study for preventing nausea and vomiting by switching from pranisetron + dexamethasone (Days 1–3) + aprepitant (Days 1–3) to palonosetron + pexamethasone (Day 1) in patients undergoing moderately emetogenic chemotherapy. (20th December 2016) Authors: Kimura, T.; Otsuka, K.; Yaegashi, M.; Hakozaki, M.; Matuo, T.; Fujii, H.; Sato, K.; Kamishima, M.; Miyake, T.; Takahara, T.; Akiyama, Y.; Iwaya, T.; Nishizuka, S.; Nitta, H.; Koeda, K.; Mizuno, M.; Kimura, Y.; Sasaki, A. Journal: Annals of oncology Issue: Volume 27(2016:Sep.)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗